GUAIFENESIN

GUAIFENESIN was reported 164926 times

GUAIFENESIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 35 0.1155
1 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 35 0.0330
2 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 20 0.0262
3 HYPERPARATHYROIDISM SECONDARY 63 0.0251
4 RHONCHI 33 0.0239
5 NEPHROGENIC ANAEMIA 110 0.0237
6 INFUSION SITE DISCHARGE 39 0.0222
7 PRODUCT SIZE ISSUE 116 0.0216
8 FEMALE GENITAL TRACT FISTULA 36 0.0211
9 CHRONIC RESPIRATORY FAILURE 25 0.0207
10 BRONCHITIS CHRONIC 50 0.0205
11 FOREIGN BODY IN RESPIRATORY TRACT 26 0.0198
12 REDUCED FACIAL EXPRESSION 20 0.0197
13 INCORRECT DRUG ADMINISTRATION DURATION 552 0.0196
14 PNEUMONIA PSEUDOMONAL 30 0.0195
15 INFUSION SITE MASS 21 0.0193
16 RADICULOPATHY 47 0.0178
17 CHRONIC SINUSITIS 65 0.0173
18 REBOUND ACID HYPERSECRETION 52 0.0172
19 SPUTUM INCREASED 37 0.0171
20 ACUTE SINUSITIS 29 0.0168
21 INFUSION SITE PRURITUS 52 0.0165
22 ESSENTIAL HYPERTENSION 30 0.0164
23 SEASONAL ALLERGY 228 0.0161
24 OBLITERATIVE BRONCHIOLITIS 21 0.0160
25 MULTIPLE ALLERGIES 117 0.0149
26 INFUSION SITE RASH 20 0.0146
27 INCORRECT PRODUCT ADMINISTRATION DURATION 314 0.0145
28 PROCTITIS 38 0.0136
29 LOWER RESPIRATORY TRACT CONGESTION 23 0.0135
30 BREATH SOUNDS ABNORMAL 66 0.0134
31 INFUSION SITE HAEMORRHAGE 44 0.0134
32 UPPER-AIRWAY COUGH SYNDROME 110 0.0133
33 INFUSION SITE BRUISING 28 0.0130
34 ECHOCARDIOGRAM ABNORMAL 18 0.0129
35 CONTRAST MEDIA ALLERGY 23 0.0125
36 PARANASAL SINUS DISCOMFORT 47 0.0124
37 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 628 0.0120
38 CONDUCTION DISORDER 22 0.0120
39 RESPIRATORY TRACT CONGESTION 189 0.0119
40 ACCIDENTAL OVERDOSE 432 0.0118
41 FOREIGN BODY 47 0.0117
42 INFUSION SITE ERYTHEMA 97 0.0115
43 LOBAR PNEUMONIA 21 0.0113
44 PARANASAL SINUS HYPERSECRETION 43 0.0113
45 FOREIGN BODY IN THROAT 35 0.0111
46 ATELECTASIS 105 0.0109
47 PRODUCTIVE COUGH 518 0.0108
48 INFUSION SITE SWELLING 68 0.0108
49 PRE-EXISTING CONDITION IMPROVED 66 0.0106
50 MIDDLE EAR EFFUSION 23 0.0104
51 INFUSION SITE PAIN 131 0.0102
52 COMPUTERISED TOMOGRAM ABNORMAL 23 0.0101
53 SINUS DISORDER 199 0.0100
54 ORTHOPNOEA 32 0.0100
55 ECONOMIC PROBLEM 152 0.0100
56 BRONCHIECTASIS 66 0.0098
57 CHOKING SENSATION 54 0.0098
58 SINUS CONGESTION 132 0.0098
59 EMPHYSEMA 98 0.0097
60 RHINITIS ALLERGIC 43 0.0096
61 BRONCHITIS 713 0.0096
62 BRAIN NATRIURETIC PEPTIDE INCREASED 29 0.0094
63 RHINOVIRUS INFECTION 36 0.0092
64 UPPER RESPIRATORY TRACT INFECTION 425 0.0092
65 SPUTUM DISCOLOURED 87 0.0092
66 ISCHAEMIC CARDIOMYOPATHY 28 0.0091
67 PNEUMONIA STAPHYLOCOCCAL 18 0.0091
68 END STAGE RENAL DISEASE 166 0.0091
69 INCREASED BRONCHIAL SECRETION 23 0.0090
70 INCREASED UPPER AIRWAY SECRETION 46 0.0090
71 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 262 0.0089
72 SECRETION DISCHARGE 112 0.0089
73 PERIPHERAL VASCULAR DISORDER 46 0.0089
74 OXYGEN CONSUMPTION INCREASED 21 0.0088
75 RALES 51 0.0088
76 NASAL DRYNESS 55 0.0088
77 ACUTE RESPIRATORY FAILURE 168 0.0087
78 ORAL CANDIDIASIS 114 0.0086
79 SINUSITIS 877 0.0085
80 RESPIRATORY TRACT INFECTION 222 0.0085
81 OBSTRUCTION 34 0.0085
82 DEVICE INFUSION ISSUE 21 0.0085
83 INFUSION SITE INFECTION 19 0.0082
84 SLEEP APNOEA SYNDROME 155 0.0081
85 CANDIDIASIS 32 0.0080
86 BLOOD LOSS ANAEMIA 18 0.0079
87 INFUSION SITE EXTRAVASATION 49 0.0079
88 HAEMOPTYSIS 218 0.0078
89 PSEUDOMONAS INFECTION 67 0.0078
90 BLOOD CHLORIDE DECREASED 20 0.0077
91 CARDIOMEGALY 95 0.0077
92 INFUSION SITE REACTION 23 0.0077
93 HYPERVOLAEMIA 38 0.0077
94 LISTLESS 25 0.0076
95 SINUS HEADACHE 45 0.0076
96 BENIGN PROSTATIC HYPERPLASIA 39 0.0075
97 CHEST X-RAY ABNORMAL 23 0.0075
98 LEFT VENTRICULAR HYPERTROPHY 32 0.0075
99 CHRONIC KIDNEY DISEASE 563 0.0074
100 DECUBITUS ULCER 60 0.0074
101 PULMONARY CONGESTION 95 0.0072
102 LUMBAR SPINAL STENOSIS 21 0.0072
103 INCORRECT DRUG ADMINISTRATION RATE 30 0.0070
104 HYPERLIPIDAEMIA 84 0.0070
105 INSURANCE ISSUE 107 0.0070
106 AORTIC ARTERIOSCLEROSIS 18 0.0070
107 HYPOXIA 246 0.0070
108 SPINAL OSTEOARTHRITIS 61 0.0069
109 DRY THROAT 70 0.0069
110 PRODUCT ADMINISTRATION INTERRUPTED 54 0.0069
111 EXPIRED PRODUCT ADMINISTERED 228 0.0069
112 DERMATITIS CONTACT 78 0.0068
113 NASAL CONGESTION 391 0.0066
114 PNEUMONIA BACTERIAL 61 0.0066
115 NON-CARDIAC CHEST PAIN 21 0.0066
116 INTERVERTEBRAL DISC DEGENERATION 61 0.0066
117 TRICUSPID VALVE INCOMPETENCE 52 0.0065
118 PRODUCT USE COMPLAINT 103 0.0065
119 PULMONARY HYPERTENSION 136 0.0065
120 RENAL FAILURE CHRONIC 50 0.0065
121 CHOKING 125 0.0064
122 HAEMORRHAGIC ANAEMIA 28 0.0064
123 DYSPNOEA EXERTIONAL 239 0.0063
124 OXYGEN SATURATION ABNORMAL 18 0.0063
125 PNEUMONIA FUNGAL 25 0.0063
126 DIVERTICULUM 45 0.0063
127 PNEUMONIA VIRAL 20 0.0063
128 CEREBRAL ATROPHY 25 0.0063
129 OXYGEN SATURATION DECREASED 348 0.0062
130 CYSTIC FIBROSIS 34 0.0061
131 DIABETIC NEUROPATHY 30 0.0061
132 DIVERTICULUM INTESTINAL 26 0.0059
133 SPINAL COLUMN STENOSIS 28 0.0059
134 SKIN ABRASION 28 0.0059
135 MITRAL VALVE INCOMPETENCE 67 0.0059
136 PELVIC FRACTURE 46 0.0059
137 ARTERIOSCLEROSIS CORONARY ARTERY 39 0.0059
138 MASTICATION DISORDER 18 0.0059
139 MUSCULOSKELETAL CHEST PAIN 91 0.0059
140 COUGH 1641 0.0058
141 WHEEZING 346 0.0058
142 EAR INFECTION 155 0.0058
143 CARDIAC MURMUR 50 0.0058
144 EAR DISCOMFORT 59 0.0057
145 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 39 0.0057
146 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 31 0.0057
147 HOSPICE CARE 56 0.0057
148 PULMONARY MASS 83 0.0056
149 MULTIPLE INJURIES 35 0.0056
150 LUNG INFILTRATION 49 0.0055
151 MACULAR DEGENERATION 66 0.0055
152 IMMOBILE 24 0.0055
153 LUNG NEOPLASM 23 0.0054
154 FEELING JITTERY 101 0.0053
155 PNEUMONIA 1710 0.0053
156 AORTIC ANEURYSM 40 0.0053
157 MEDICATION RESIDUE PRESENT 25 0.0052
158 RESPIRATION ABNORMAL 36 0.0052
159 FAILURE TO THRIVE 27 0.0052
160 GASTROOESOPHAGEAL REFLUX DISEASE 411 0.0051
161 PROSTATOMEGALY 20 0.0051
162 EXPIRED DRUG ADMINISTERED 25 0.0050
163 VIRAL UPPER RESPIRATORY TRACT INFECTION 24 0.0050
164 EAR PAIN 98 0.0050
165 SNORING 19 0.0050
166 SUPRAVENTRICULAR TACHYCARDIA 48 0.0050
167 ARTHROPOD BITE 37 0.0050
168 PRODUCT SOLUBILITY ABNORMAL 25 0.0049
169 RESPIRATORY SYNCYTIAL VIRUS INFECTION 43 0.0049
170 PARAESTHESIA ORAL 71 0.0049
171 VENTRICULAR EXTRASYSTOLES 51 0.0049
172 ANHEDONIA 129 0.0049
173 TRIGGER FINGER 20 0.0049
174 ARTERIOSCLEROSIS 46 0.0049
175 CARDIAC FAILURE CONGESTIVE 392 0.0049
176 RHINORRHOEA 315 0.0049
177 LUNG INFECTION 75 0.0048
178 VITAMIN D DEFICIENCY 47 0.0048
179 PULMONARY FUNCTION TEST DECREASED 21 0.0048
180 ASTHMA 540 0.0048
181 DYSPHONIA 279 0.0048
182 PHARYNGITIS 59 0.0048
183 LIGAMENT SPRAIN 47 0.0047
184 OSTEOPENIA 72 0.0047
185 CATHETERISATION CARDIAC 21 0.0047
186 DYSLIPIDAEMIA 24 0.0047
187 SOMNAMBULISM 31 0.0047
188 BACTERIAL INFECTION 88 0.0047
189 PLEURISY 28 0.0047
190 RHINITIS 38 0.0047
191 AORTIC VALVE INCOMPETENCE 20 0.0047
192 INTERNATIONAL NORMALISED RATIO DECREASED 19 0.0047
193 RETCHING 100 0.0047
194 RENAL CYST 37 0.0047
195 VAGINAL DISCHARGE 47 0.0046
196 ATRIAL FLUTTER 37 0.0046
197 DISEASE RECURRENCE 220 0.0046
198 HORDEOLUM 20 0.0046
199 TENDERNESS 48 0.0046
200 SPINAL COMPRESSION FRACTURE 38 0.0046
201 RIGHT VENTRICULAR FAILURE 32 0.0046
202 IDIOPATHIC PULMONARY FIBROSIS 18 0.0045
203 IRON DEFICIENCY ANAEMIA 42 0.0045
204 GASTROENTERITIS VIRAL 82 0.0045
205 ECCHYMOSIS 31 0.0045
206 COVID-19 PNEUMONIA 53 0.0045
207 CARDIAC FLUTTER 29 0.0045
208 PNEUMONIA ASPIRATION 112 0.0045
209 BUNDLE BRANCH BLOCK LEFT 19 0.0045
210 POST-TRAUMATIC STRESS DISORDER 30 0.0045
211 FLUID OVERLOAD 65 0.0045
212 CANDIDA INFECTION 75 0.0044
213 OROPHARYNGEAL DISCOMFORT 40 0.0044
214 EPISTAXIS 330 0.0044
215 BLOOD SODIUM DECREASED 83 0.0044
216 ATRIOVENTRICULAR BLOCK FIRST DEGREE 19 0.0044
217 TONGUE DISCOLOURATION 19 0.0043
218 LYMPHOEDEMA 30 0.0043
219 CLOSTRIDIUM DIFFICILE COLITIS 46 0.0043
220 COVID-19 761 0.0043
221 SKIN LACERATION 47 0.0043
222 BODY HEIGHT DECREASED 46 0.0043
223 COMPRESSION FRACTURE 23 0.0043
224 NASAL DISCOMFORT 34 0.0043
225 RIB FRACTURE 88 0.0043
226 FOOD ALLERGY 33 0.0043
227 GINGIVITIS 23 0.0043
228 HIATUS HERNIA 55 0.0042
229 ABSCESS LIMB 18 0.0042
230 PURULENT DISCHARGE 18 0.0042
231 BLOOD IRON DECREASED 50 0.0042
232 THROAT IRRITATION 189 0.0042
233 RENAL TUBULAR NECROSIS 41 0.0042
234 OROPHARYNGEAL PAIN 386 0.0042
235 EYE INFECTION 47 0.0042
236 FAECES DISCOLOURED 90 0.0041
237 EAR DISORDER 19 0.0041
238 ANOSMIA 60 0.0041
239 PHARYNGOLARYNGEAL PAIN 22 0.0041
240 RESPIRATORY FAILURE 301 0.0041
241 MAJOR DEPRESSION 30 0.0041
242 HEAD DISCOMFORT 72 0.0041
243 LOWER GASTROINTESTINAL HAEMORRHAGE 30 0.0041
244 RENAL FAILURE 538 0.0040
245 AGEUSIA 101 0.0040
246 CELLULITIS 204 0.0040
247 CARDIAC VALVE DISEASE 23 0.0040
248 ASPIRATION 44 0.0040
249 PROTHROMBIN TIME PROLONGED 24 0.0040
250 APHONIA 56 0.0040
251 VIRAL INFECTION 133 0.0040
252 DYSPNOEA 2260 0.0040
253 ROTATOR CUFF SYNDROME 51 0.0040
254 PLEURAL EFFUSION 241 0.0040
255 MUSCLE STRAIN 34 0.0039
256 BRONCHOSPASM 56 0.0039
257 INCREASED TENDENCY TO BRUISE 36 0.0039
258 URINE ODOUR ABNORMAL 23 0.0039
259 RENAL INJURY 116 0.0039
260 CHOLECYSTITIS CHRONIC 26 0.0039
261 BLOOD UREA INCREASED 65 0.0039
262 PHARYNGITIS STREPTOCOCCAL 42 0.0039
263 PULMONARY FIBROSIS 74 0.0039
264 URINARY TRACT INFECTION 658 0.0039
265 WOUND INFECTION 42 0.0038
266 TOOTH ABSCESS 39 0.0038
267 TYPE 1 DIABETES MELLITUS 23 0.0038
268 POOR QUALITY SLEEP 82 0.0038
269 HYPERKERATOSIS 21 0.0038
270 INITIAL INSOMNIA 39 0.0038
271 CORONARY ARTERY DISEASE 115 0.0038
272 SNEEZING 85 0.0038
273 GOUT 68 0.0038
274 LUNG DISORDER 185 0.0038
275 ATRIAL FIBRILLATION 367 0.0038
276 HEART RATE IRREGULAR 85 0.0038
277 RESPIRATORY DISORDER 112 0.0037
278 AFFECT LABILITY 36 0.0037
279 FOOD POISONING 20 0.0037
280 NASOPHARYNGITIS 687 0.0037
281 PNEUMOTHORAX 59 0.0037
282 GLUCOSE TOLERANCE IMPAIRED 22 0.0037
283 HYPOAESTHESIA ORAL 56 0.0037
284 BLOOD MAGNESIUM DECREASED 32 0.0037
285 RESPIRATORY DISTRESS 102 0.0037
286 CHEST DISCOMFORT 378 0.0037
287 INCONTINENCE 39 0.0037
288 POLYP 24 0.0037
289 PRODUCT DISTRIBUTION ISSUE 34 0.0037
290 OESOPHAGITIS 40 0.0037
291 FUNGAL INFECTION 122 0.0037
292 BLOOD POTASSIUM DECREASED 110 0.0037
293 PULMONARY ARTERIAL HYPERTENSION 53 0.0037
294 OBESITY 58 0.0036
295 THERAPEUTIC RESPONSE UNEXPECTED 163 0.0036
296 WEIGHT FLUCTUATION 38 0.0036
297 DECREASED ACTIVITY 39 0.0036
298 SINUS TACHYCARDIA 51 0.0036
299 CARDIOMYOPATHY 53 0.0036
300 DECREASED INTEREST 21 0.0036
301 EYE DISCHARGE 37 0.0036
302 HYPOKALAEMIA 163 0.0035
303 HAEMATOCRIT DECREASED 70 0.0035
304 DRY MOUTH 286 0.0035
305 JOINT INJURY 75 0.0035
306 INTERNAL HAEMORRHAGE 40 0.0035
307 FLUID RETENTION 178 0.0035
308 CARPAL TUNNEL SYNDROME 49 0.0035
309 LIMB INJURY 95 0.0035
310 BACK INJURY 38 0.0035
311 MENTAL STATUS CHANGES 97 0.0035
312 TOOTH INFECTION 46 0.0035
313 STAPHYLOCOCCAL INFECTION 115 0.0035
314 MALNUTRITION 39 0.0035
315 LEUKOCYTOSIS 63 0.0035
316 BLOOD PRESSURE INCREASED 531 0.0035
317 INTERNATIONAL NORMALISED RATIO INCREASED 99 0.0035
318 THIRST 62 0.0035
319 LARGE INTESTINE POLYP 24 0.0035
320 PAIN IN JAW 98 0.0035
321 TONGUE DISORDER 25 0.0035
322 BACK DISORDER 56 0.0034
323 ELECTROCARDIOGRAM ABNORMAL 27 0.0034
324 TRANSFUSION 36 0.0034
325 HEART RATE INCREASED 340 0.0034
326 URINE OUTPUT DECREASED 30 0.0034
327 MUSCULOSKELETAL DISCOMFORT 59 0.0034
328 BEDRIDDEN 45 0.0034
329 OEDEMA PERIPHERAL 417 0.0034
330 HYPERCHOLESTEROLAEMIA 33 0.0034
331 ABNORMAL FAECES 28 0.0034
332 PERICARDIAL EFFUSION 79 0.0034
333 FLANK PAIN 32 0.0034
334 RESTLESS LEGS SYNDROME 62 0.0034
335 BLOOD ALBUMIN DECREASED 27 0.0034
336 EXOSTOSIS 31 0.0034
337 SCOLIOSIS 21 0.0034
338 HAND FRACTURE 24 0.0034
339 SKIN INFECTION 38 0.0034
340 INTERVERTEBRAL DISC PROTRUSION 74 0.0034
341 HAEMORRHOIDS 66 0.0034
342 OSTEOARTHRITIS 143 0.0034
343 TOOTH DISORDER 75 0.0034
344 THROAT TIGHTNESS 91 0.0034
345 DENTAL CARIES 37 0.0033
346 IMPAIRED QUALITY OF LIFE 48 0.0033
347 SQUAMOUS CELL CARCINOMA OF SKIN 20 0.0033
348 DYSPHAGIA 314 0.0033
349 GALLBLADDER DISORDER 59 0.0033
350 GROIN PAIN 29 0.0033
351 GINGIVAL PAIN 26 0.0033
352 IMMUNE SYSTEM DISORDER 43 0.0033
353 NERVOUSNESS 170 0.0033
354 NERVE COMPRESSION 30 0.0032
355 FACIAL PAIN 29 0.0032
356 INFLUENZA 362 0.0032
357 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 20 0.0032
358 SLUGGISHNESS 33 0.0032
359 FEELING DRUNK 24 0.0032
360 NO ADVERSE EVENT 582 0.0032
361 TOOTHACHE 58 0.0032
362 BLOOD POTASSIUM INCREASED 52 0.0032
363 SCIATICA 51 0.0032
364 ONYCHOCLASIS 22 0.0032
365 LACERATION 30 0.0032
366 CARDIAC PACEMAKER INSERTION 19 0.0032
367 PHARYNGEAL OEDEMA 49 0.0032
368 ELECTROLYTE IMBALANCE 37 0.0032
369 SARS-COV-2 TEST POSITIVE 42 0.0032
370 DEHYDRATION 424 0.0032
371 DYSGEUSIA 236 0.0032
372 INSOMNIA 846 0.0032
373 PULMONARY OEDEMA 142 0.0032
374 ORAL DISCOMFORT 44 0.0032
375 BLOOD URINE PRESENT 60 0.0032
376 CONTUSION 304 0.0032
377 GASTRITIS 83 0.0032
378 LIP SWELLING 105 0.0031
379 NECK PAIN 176 0.0031
380 VENTRICULAR TACHYCARDIA 52 0.0031
381 UNRESPONSIVE TO STIMULI 81 0.0031
382 OSTEOPOROSIS 129 0.0031
383 LEFT VENTRICULAR DYSFUNCTION 21 0.0031
384 ACUTE KIDNEY INJURY 479 0.0031
385 EUPHORIC MOOD 32 0.0031
386 BLOOD PRESSURE ABNORMAL 62 0.0031
387 COLITIS ISCHAEMIC 21 0.0031
388 FOOT FRACTURE 59 0.0031
389 POSTOPERATIVE WOUND INFECTION 21 0.0031
390 SWOLLEN TONGUE 97 0.0031
391 CHROMATURIA 70 0.0031
392 TENDONITIS 48 0.0031
393 OEDEMA 168 0.0031
394 MENISCUS INJURY 19 0.0031
395 ORAL PAIN 69 0.0031
396 RED BLOOD CELL COUNT DECREASED 88 0.0031
397 HYPOVOLAEMIA 18 0.0031
398 DYSURIA 113 0.0031
399 POLLAKIURIA 127 0.0030
400 DROOLING 21 0.0030
401 CHEST PAIN 563 0.0030
402 PRODUCT USE IN UNAPPROVED INDICATION 751 0.0030
403 DYSPEPSIA 297 0.0030
404 ODYNOPHAGIA 18 0.0030
405 CYSTITIS 96 0.0030
406 CONSTIPATION 657 0.0030
407 PHOTOPSIA 19 0.0030
408 HERPES ZOSTER 172 0.0030
409 DIZZINESS POSTURAL 29 0.0030
410 FULL BLOOD COUNT DECREASED 60 0.0030
411 MICTURITION URGENCY 34 0.0030
412 INJURY 209 0.0030
413 POST PROCEDURAL COMPLICATION 57 0.0030
414 BURSITIS 36 0.0030
415 URINARY RETENTION 99 0.0030
416 HYPERSOMNIA 85 0.0030
417 SPINAL DISORDER 28 0.0030
418 FLATULENCE 167 0.0029
419 DEEP VEIN THROMBOSIS 191 0.0029
420 PULMONARY THROMBOSIS 32 0.0029
421 LIVER FUNCTION TEST INCREASED 63 0.0029
422 ILLNESS 302 0.0029
423 ORTHOSTATIC HYPOTENSION 51 0.0029
424 DIVERTICULITIS 81 0.0029
425 WRIST FRACTURE 35 0.0029
426 PANIC REACTION 21 0.0029
427 DIZZINESS 1451 0.0029
428 ANKLE FRACTURE 45 0.0029
429 GASTROINTESTINAL INFECTION 26 0.0029
430 MIDDLE INSOMNIA 54 0.0029
431 TROPONIN INCREASED 22 0.0029
432 NEURALGIA 70 0.0029
433 HYPERTENSION 609 0.0029
434 SOMNOLENCE 578 0.0029
435 GASTROINTESTINAL HAEMORRHAGE 239 0.0029
436 FREQUENT BOWEL MOVEMENTS 77 0.0028
437 IRRITABLE BOWEL SYNDROME 61 0.0028
438 CLOSTRIDIUM DIFFICILE INFECTION 62 0.0028
439 CHOLELITHIASIS 93 0.0028
440 URINARY INCONTINENCE 84 0.0028
441 NEPHROLITHIASIS 130 0.0028
442 ANXIETY 803 0.0028
443 PALPITATIONS 330 0.0028
444 SPLENOMEGALY 33 0.0028
445 WEIGHT DECREASED 786 0.0028
446 TASTE DISORDER 57 0.0028
447 BRAIN FOG 44 0.0028
448 GLAUCOMA 54 0.0028
449 HYPOMAGNESAEMIA 39 0.0028
450 PRODUCT USE ISSUE 526 0.0028
451 BONE DISORDER 51 0.0028
452 HAEMOGLOBIN ABNORMAL 18 0.0028
453 PRESYNCOPE 68 0.0028
454 TACHYPNOEA 38 0.0028
455 FEELING ABNORMAL 668 0.0028
456 CATARACT 166 0.0028
457 IMPAIRED GASTRIC EMPTYING 38 0.0028
458 NEPHROPATHY 26 0.0028
459 SEPSIS 309 0.0028
460 FALL 922 0.0028
461 ANGINA UNSTABLE 18 0.0028
462 SMALL INTESTINAL OBSTRUCTION 34 0.0028
463 FIBROMYALGIA 67 0.0028
464 PNEUMONITIS 75 0.0028
465 PERIPHERAL SWELLING 424 0.0027
466 CONJUNCTIVITIS 51 0.0027
467 RECTAL HAEMORRHAGE 118 0.0027
468 COLITIS 104 0.0027
469 ENCEPHALOPATHY 67 0.0027
470 IMPAIRED DRIVING ABILITY 31 0.0027
471 TOOTH FRACTURE 30 0.0027
472 INFUSION RELATED REACTION 180 0.0027
473 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 149 0.0027
474 LACRIMATION INCREASED 82 0.0027
475 TEMPERATURE INTOLERANCE 28 0.0027
476 LABORATORY TEST ABNORMAL 80 0.0027
477 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 21 0.0027
478 CARDIAC FAILURE ACUTE 18 0.0027
479 COAGULOPATHY 45 0.0027
480 SINUS BRADYCARDIA 26 0.0027
481 SCAR 46 0.0027
482 EATING DISORDER 57 0.0027
483 HYDRONEPHROSIS 20 0.0027
484 BACK PAIN 620 0.0027
485 BIPOLAR DISORDER 29 0.0027
486 DRY EYE 133 0.0027
487 DIARRHOEA 1717 0.0027
488 PHARYNGEAL SWELLING 26 0.0027
489 UNEVALUABLE EVENT 201 0.0027
490 SQUAMOUS CELL CARCINOMA 25 0.0027
491 SCRATCH 28 0.0027
492 KIDNEY INFECTION 52 0.0026
493 FRACTURE 50 0.0026
494 RENAL PAIN 28 0.0026
495 GLOSSODYNIA 59 0.0026
496 PROCEDURAL PAIN 73 0.0026
497 ABDOMINAL PAIN UPPER 539 0.0026
498 UPPER GASTROINTESTINAL HAEMORRHAGE 44 0.0026
499 UPPER LIMB FRACTURE 52 0.0026
500 LETHARGY 150 0.0026
501 CHILLS 304 0.0026
502 ORAL DISORDER 19 0.0026
503 HEAD INJURY 82 0.0026
504 PRODUCT TASTE ABNORMAL 35 0.0026
505 CONCUSSION 20 0.0026
506 VITAMIN D DECREASED 22 0.0026
507 RESTLESSNESS 94 0.0026
508 LOCALISED INFECTION 62 0.0026
509 PULMONARY HAEMORRHAGE 20 0.0026
510 HYPONATRAEMIA 144 0.0026
511 PULMONARY EMBOLISM 242 0.0025
512 LYMPHADENOPATHY 90 0.0025
513 SPEECH DISORDER 133 0.0025
514 ASTHENIA 952 0.0025
515 ACTIVITIES OF DAILY LIVING IMPAIRED 50 0.0025
516 ARTHRITIS 197 0.0025
517 HEADACHE 1570 0.0025
518 BLOOD DISORDER 20 0.0025
519 UROSEPSIS 23 0.0025
520 OBSESSIVE-COMPULSIVE DISORDER 20 0.0025
521 HIP FRACTURE 80 0.0025
522 HYPOTENSION 499 0.0025
523 IMMUNODEFICIENCY 37 0.0025
524 FAECES SOFT 18 0.0025
525 RENAL FAILURE ACUTE 105 0.0025
526 NOCTURIA 30 0.0025
527 DYSARTHRIA 93 0.0025
528 HEPATIC STEATOSIS 46 0.0025
529 GASTROENTERITIS 36 0.0025
530 INFECTION 357 0.0025
531 SCAB 28 0.0025
532 TUBULOINTERSTITIAL NEPHRITIS 46 0.0025
533 HAEMATURIA 84 0.0025
534 NIGHT SWEATS 79 0.0024
535 PRURITUS GENERALISED 53 0.0024
536 ABDOMINAL DISCOMFORT 411 0.0024
537 WHITE BLOOD CELL COUNT INCREASED 94 0.0024
538 TREMOR 406 0.0024
539 ABDOMINAL DISTENSION 254 0.0024
540 NERVE INJURY 27 0.0024
541 GASTRIC ULCER 46 0.0024
542 BLADDER DISORDER 24 0.0024
543 POOR VENOUS ACCESS 25 0.0024
544 PANIC ATTACK 88 0.0024
545 HAEMATOCHEZIA 133 0.0024
546 LIVER FUNCTION TEST ABNORMAL 70 0.0024
547 ANAEMIA 458 0.0024
548 THYROID DISORDER 37 0.0024
549 FATIGUE 1852 0.0024
550 MIGRAINE 226 0.0024
551 CHOLECYSTECTOMY 27 0.0024
552 VERTIGO 144 0.0024
553 BACTERAEMIA 28 0.0024
554 BODY TEMPERATURE INCREASED 48 0.0024
555 SLEEP DISORDER 166 0.0023
556 BOWEL MOVEMENT IRREGULARITY 18 0.0023
557 BODY TEMPERATURE DECREASED 23 0.0023
558 EMOTIONAL DISORDER 72 0.0023
559 HEART RATE DECREASED 82 0.0023
560 FEELING COLD 65 0.0023
561 NEUROPATHY PERIPHERAL 222 0.0023
562 TOOTH EXTRACTION 29 0.0023
563 ATRIOVENTRICULAR BLOCK 18 0.0023
564 HYPOACUSIS 100 0.0023
565 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 165 0.0023
566 ABSCESS 37 0.0023
567 FEEDING DISORDER 47 0.0023
568 TYPE 2 DIABETES MELLITUS 78 0.0023
569 OCULAR DISCOMFORT 26 0.0023
570 TRANSIENT ISCHAEMIC ATTACK 78 0.0023
571 DECREASED APPETITE 534 0.0023
572 SALIVARY HYPERSECRETION 23 0.0023
573 SPINAL FRACTURE 46 0.0023
574 DYSSTASIA 67 0.0023
575 MUSCLE SPASMS 421 0.0023
576 NAUSEA 1814 0.0023
577 ARTERIAL OCCLUSIVE DISEASE 18 0.0023
578 PSYCHOMOTOR HYPERACTIVITY 38 0.0023
579 HYPOTHYROIDISM 73 0.0023
580 EOSINOPHIL COUNT INCREASED 19 0.0023
581 INTENTIONAL DOSE OMISSION 65 0.0023
582 HERNIA 44 0.0023
583 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 410 0.0023
584 THROMBOSIS 183 0.0023
585 JOINT DISLOCATION 24 0.0023
586 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 109 0.0023
587 ATRIAL SEPTAL DEFECT 19 0.0023
588 RASH MACULAR 79 0.0023
589 THINKING ABNORMAL 42 0.0023
590 EYE DISORDER 74 0.0022
591 SKIN ULCER 58 0.0022
592 VITREOUS FLOATERS 22 0.0022
593 JOINT RANGE OF MOTION DECREASED 30 0.0022
594 BALANCE DISORDER 193 0.0022
595 HYPOPHAGIA 57 0.0022
596 PYREXIA 770 0.0022
597 DEPRESSION 505 0.0022
598 SPINAL PAIN 26 0.0022
599 DEAFNESS 58 0.0022
600 HOT FLUSH 167 0.0022
601 PAIN IN EXTREMITY 650 0.0022
602 ORAL HERPES 43 0.0022
603 HAEMATOMA 57 0.0022
604 MUSCLE SPASTICITY 27 0.0022
605 HYSTERECTOMY 19 0.0022
606 SWELLING 205 0.0022
607 SKIN LESION 60 0.0022
608 HYPERSENSITIVITY 406 0.0022
609 LOCAL SWELLING 38 0.0022
610 HALLUCINATION 164 0.0022
611 MUSCULOSKELETAL PAIN 114 0.0022
612 EYE PRURITUS 73 0.0022
613 CONFUSIONAL STATE 351 0.0022
614 HAEMOGLOBIN DECREASED 223 0.0022
615 PRODUCT DOSE OMISSION IN ERROR 61 0.0022
616 SYNCOPE 215 0.0021
617 MASS 30 0.0021
618 DIABETES MELLITUS 163 0.0021
619 PHOTOPHOBIA 40 0.0021
620 ERUCTATION 41 0.0021
621 BASAL CELL CARCINOMA 33 0.0021
622 DEMENTIA 59 0.0021
623 TENDON RUPTURE 26 0.0021
624 PAIN 1292 0.0021
625 RENAL DISORDER 98 0.0021
626 ACUTE MYOCARDIAL INFARCTION 62 0.0021
627 COLD SWEAT 37 0.0021
628 VISION BLURRED 288 0.0021
629 GASTROINTESTINAL PAIN 23 0.0021
630 SWELLING FACE 136 0.0021
631 VOMITING 980 0.0021
632 BLOOD CHOLESTEROL INCREASED 97 0.0021
633 ULCER 33 0.0021
634 RASH PRURITIC 112 0.0021
635 ABNORMAL DREAMS 57 0.0021
636 BLOOD ALKALINE PHOSPHATASE INCREASED 51 0.0021
637 GAIT DISTURBANCE 393 0.0021
638 OSTEOMYELITIS 37 0.0020
639 EYE SWELLING 76 0.0020
640 BLOOD PRESSURE FLUCTUATION 49 0.0020
641 MUSCULAR WEAKNESS 232 0.0020
642 IMMUNOSUPPRESSION 18 0.0020
643 PERIPHERAL COLDNESS 28 0.0020
644 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 413 0.0020
645 MUSCLE TIGHTNESS 33 0.0020
646 HALLUCINATION, VISUAL 43 0.0020
647 ROAD TRAFFIC ACCIDENT 85 0.0020
648 BLOOD PRESSURE DECREASED 135 0.0020
649 LOWER LIMB FRACTURE 39 0.0020
650 SPINAL OPERATION 25 0.0020
651 HYPERHIDROSIS 261 0.0020
652 TACHYCARDIA 180 0.0020
653 ATAXIA 24 0.0020
654 MYOCARDIAL ISCHAEMIA 23 0.0020
655 MALIGNANT MELANOMA 27 0.0020
656 SURGERY 118 0.0020
657 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 34 0.0020
658 SKIN CANCER 43 0.0020
659 EJECTION FRACTION DECREASED 31 0.0020
660 DISORIENTATION 79 0.0020
661 APATHY 29 0.0020
662 CONDITION AGGRAVATED 603 0.0020
663 MALAISE 869 0.0020
664 VENTRICULAR FIBRILLATION 22 0.0020
665 SKIN DISCOLOURATION 91 0.0020
666 ASPARTATE AMINOTRANSFERASE INCREASED 105 0.0020
667 FEELING HOT 121 0.0020
668 DEVICE FAILURE 30 0.0020
669 PRESCRIBED OVERDOSE 38 0.0020
670 LOWER RESPIRATORY TRACT INFECTION 89 0.0020
671 BONE PAIN 114 0.0019
672 PRODUCT DOSE OMISSION ISSUE 571 0.0019
673 JOINT SWELLING 234 0.0019
674 QUALITY OF LIFE DECREASED 26 0.0019
675 ILEUS 24 0.0019
676 CHOLECYSTITIS 23 0.0019
677 COMPLICATION ASSOCIATED WITH DEVICE 28 0.0019
678 ACUTE RESPIRATORY DISTRESS SYNDROME 34 0.0019
679 DISABILITY 38 0.0019
680 DIABETES MELLITUS INADEQUATE CONTROL 34 0.0019
681 OCULAR HYPERAEMIA 91 0.0019
682 DRUG INEFFECTIVE 2523 0.0019
683 GASTRIC HAEMORRHAGE 22 0.0019
684 CORONARY ARTERY OCCLUSION 26 0.0019
685 CARDIAC DISORDER 177 0.0019
686 LOSS OF CONSCIOUSNESS 242 0.0019
687 OVERDOSE 407 0.0019
688 SEPTIC SHOCK 82 0.0019
689 STOMATITIS 114 0.0019
690 PHOTOSENSITIVITY REACTION 31 0.0019
691 BLOOD CALCIUM DECREASED 21 0.0019
692 MYELODYSPLASTIC SYNDROME 27 0.0019
693 URTICARIA 312 0.0019
694 EYE PAIN 105 0.0019
695 ILL-DEFINED DISORDER 113 0.0019
696 GENERALISED OEDEMA 23 0.0019
697 HYPOAESTHESIA 278 0.0019
698 BURNING SENSATION 130 0.0019
699 CYST 23 0.0019
700 BRADYCARDIA 98 0.0018
701 BLOOD COUNT ABNORMAL 28 0.0018
702 BLOOD CREATININE INCREASED 120 0.0018
703 ABDOMINAL PAIN 427 0.0018
704 MEMORY IMPAIRMENT 252 0.0018
705 GAIT INABILITY 61 0.0018
706 PETECHIAE 19 0.0018
707 BONE DENSITY DECREASED 57 0.0018
708 CARDIO-RESPIRATORY ARREST 76 0.0018
709 RASH GENERALISED 47 0.0018
710 ANGINA PECTORIS 52 0.0018
711 PRODUCT ODOUR ABNORMAL 19 0.0018
712 DERMATITIS 38 0.0018
713 INABILITY TO AFFORD MEDICATION 18 0.0018
714 PRURITUS 695 0.0018
715 GASTRIC DISORDER 62 0.0018
716 INTESTINAL OBSTRUCTION 68 0.0018
717 PARANOIA 31 0.0018
718 COORDINATION ABNORMAL 25 0.0018
719 PLATELET COUNT DECREASED 191 0.0018
720 GLOMERULAR FILTRATION RATE DECREASED 22 0.0018
721 DISCOMFORT 109 0.0018
722 CARDIAC ARREST 147 0.0018
723 CYANOSIS 28 0.0018
724 RASH 776 0.0018
725 PARAESTHESIA 280 0.0018
726 COGNITIVE DISORDER 83 0.0018
727 ALANINE AMINOTRANSFERASE INCREASED 109 0.0018
728 TARDIVE DYSKINESIA 50 0.0018
729 DYSKINESIA 72 0.0018
730 HYPERKALAEMIA 62 0.0018
731 AMNESIA 115 0.0018
732 METASTASES TO BONE 29 0.0018
733 NODULE 23 0.0018
734 PELVIC PAIN 32 0.0018
735 MYALGIA 299 0.0018
736 GINGIVAL BLEEDING 24 0.0018
737 HEPATIC CIRRHOSIS 33 0.0018
738 SUBDURAL HAEMATOMA 25 0.0017
739 FLUSHING 177 0.0017
740 MUSCLE ATROPHY 22 0.0017
741 PRODUCT COMPLAINT 44 0.0017
742 TREATMENT NONCOMPLIANCE 95 0.0017
743 EMOTIONAL DISTRESS 210 0.0017
744 ARTHRALGIA 721 0.0017
745 CRYING 63 0.0017
746 DIPLOPIA 45 0.0017
747 WEIGHT INCREASED 388 0.0017
748 ERYTHEMA 356 0.0017
749 DELIRIUM 60 0.0017
750 HUNGER 24 0.0017
751 POST PROCEDURAL HAEMORRHAGE 20 0.0017
752 CONTRAINDICATED PRODUCT ADMINISTERED 52 0.0017
753 WOUND 48 0.0017
754 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 122 0.0017
755 MOUTH ULCERATION 36 0.0017
756 HYPERGLYCAEMIA 62 0.0017
757 TINNITUS 78 0.0017
758 GASTROINTESTINAL DISORDER 152 0.0017
759 HAEMATEMESIS 43 0.0017
760 CYTOKINE RELEASE SYNDROME 34 0.0017
761 AGITATION 124 0.0017
762 DRUG EFFECT LESS THAN EXPECTED 25 0.0017
763 CARDIOGENIC SHOCK 24 0.0017
764 WHITE BLOOD CELL COUNT DECREASED 181 0.0017
765 RESPIRATORY ARREST 46 0.0017
766 THERAPY NON-RESPONDER 75 0.0017
767 ASCITES 49 0.0017
768 PLASMA CELL MYELOMA 65 0.0017
769 SKIN FISSURES 32 0.0016
770 IMPAIRED WORK ABILITY 35 0.0016
771 PRODUCT PHYSICAL ISSUE 33 0.0016
772 LUNG NEOPLASM MALIGNANT 67 0.0016
773 IRRITABILITY 98 0.0016
774 MUSCULOSKELETAL DISORDER 31 0.0016
775 INFLAMMATION 84 0.0016
776 ARRHYTHMIA 77 0.0016
777 BLOOD GLUCOSE DECREASED 78 0.0016
778 SKIN HAEMORRHAGE 24 0.0016
779 OBSTRUCTIVE AIRWAYS DISORDER 18 0.0016
780 DISTURBANCE IN ATTENTION 87 0.0016
781 PLATELET COUNT INCREASED 21 0.0016
782 MENTAL DISORDER 70 0.0016
783 HAIR COLOUR CHANGES 20 0.0016
784 JOINT STIFFNESS 42 0.0016
785 METASTASES TO LIVER 28 0.0016
786 HYPERTHYROIDISM 23 0.0016
787 LIMB DISCOMFORT 49 0.0016
788 ARTHROPATHY 88 0.0016
789 PRODUCT QUALITY ISSUE 214 0.0016
790 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 27 0.0016
791 BLISTER 88 0.0016
792 VISUAL IMPAIRMENT 194 0.0016
793 INTENTIONAL PRODUCT USE ISSUE 137 0.0016
794 HOSPITALISATION 240 0.0016
795 RASH PAPULAR 35 0.0016
796 DEVICE RELATED INFECTION 24 0.0016
797 MYDRIASIS 20 0.0016
798 INFLUENZA LIKE ILLNESS 128 0.0016
799 ANOREXIA 20 0.0016
800 OSTEONECROSIS OF JAW 38 0.0015
801 CEREBROVASCULAR ACCIDENT 260 0.0015
802 NIGHTMARE 53 0.0015
803 EXTRAPYRAMIDAL DISORDER 38 0.0015
804 EYE IRRITATION 88 0.0015
805 BLOOD TRIGLYCERIDES INCREASED 27 0.0015
806 RASH ERYTHEMATOUS 73 0.0015
807 FEAR 41 0.0015
808 MUSCLE TWITCHING 35 0.0015
809 BLOOD GLUCOSE ABNORMAL 28 0.0015
810 ACCIDENT 18 0.0015
811 EXTRA DOSE ADMINISTERED 61 0.0015
812 MULTI-ORGAN FAILURE 26 0.0015
813 PRODUCT DOSE OMISSION 98 0.0015
814 EYE HAEMORRHAGE 20 0.0015
815 FEBRILE NEUTROPENIA 99 0.0015
816 APHASIA 45 0.0015
817 HAEMORRHAGE 154 0.0015
818 MUSCULOSKELETAL STIFFNESS 127 0.0014
819 MOOD SWINGS 46 0.0014
820 MYOCARDIAL INFARCTION 251 0.0014
821 PANCREATITIS 76 0.0014
822 BLOOD PRESSURE SYSTOLIC INCREASED 28 0.0014
823 DRUG DOSE OMISSION 237 0.0014
824 DRUG ADMINISTRATION ERROR 44 0.0014
825 PALLOR 39 0.0014
826 MOVEMENT DISORDER 46 0.0014
827 IMPAIRED HEALING 47 0.0014
828 EXPOSURE VIA SKIN CONTACT 37 0.0014
829 BRAIN OEDEMA 18 0.0014
830 DEVICE OCCLUSION 20 0.0014
831 HEMIPARESIS 24 0.0014
832 ABASIA 35 0.0014
833 INJECTION SITE IRRITATION 18 0.0014
834 ANAPHYLACTIC REACTION 78 0.0014
835 SKIN DISORDER 47 0.0014
836 THROMBOCYTOPENIA 157 0.0014
837 THERAPY INTERRUPTED 100 0.0014
838 HEPATIC ENZYME INCREASED 95 0.0014
839 INTENTIONAL PRODUCT MISUSE 122 0.0014
840 THERAPY CESSATION 71 0.0014
841 MOBILITY DECREASED 99 0.0014
842 KNEE ARTHROPLASTY 29 0.0014
843 SEDATION 36 0.0014
844 HIP ARTHROPLASTY 21 0.0014
845 PRODUCT AVAILABILITY ISSUE 31 0.0014
846 HEPATIC FAILURE 41 0.0014
847 BLOOD TEST ABNORMAL 19 0.0014
848 ACUTE MYELOID LEUKAEMIA 21 0.0013
849 CARDIAC FAILURE 108 0.0013
850 ADVERSE DRUG REACTION 119 0.0013
851 HYPOKINESIA 19 0.0013
852 DRUG DISPENSING ERROR 20 0.0013
853 SENSORY DISTURBANCE 21 0.0013
854 SEIZURE 151 0.0013
855 BLOOD GLUCOSE INCREASED 246 0.0013
856 DEPRESSED MOOD 69 0.0013
857 SEROTONIN SYNDROME 25 0.0013
858 JAUNDICE 35 0.0013
859 DRUG INTOLERANCE 125 0.0013
860 CONVULSION 74 0.0013
861 PANCYTOPENIA 72 0.0013
862 DELUSION 20 0.0013
863 SUICIDAL IDEATION 117 0.0013
864 COLITIS ULCERATIVE 57 0.0013
865 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 43 0.0013
866 ABNORMAL BEHAVIOUR 50 0.0013
867 INCREASED APPETITE 24 0.0013
868 PRESCRIBED UNDERDOSE 25 0.0013
869 MOOD ALTERED 34 0.0012
870 MEDICATION ERROR 69 0.0012
871 LIVER DISORDER 55 0.0012
872 WRONG TECHNIQUE IN DRUG USAGE PROCESS 45 0.0012
873 DYSTONIA 24 0.0012
874 HYPOGLYCAEMIA 60 0.0012
875 PRODUCT ADMINISTRATION ERROR 25 0.0012
876 PHARMACEUTICAL PRODUCT COMPLAINT 32 0.0012
877 MELAENA 27 0.0012
878 DRUG INTERACTION 194 0.0012
879 BLOOD BILIRUBIN INCREASED 33 0.0012
880 MULTIPLE FRACTURES 20 0.0012
881 DEPRESSED LEVEL OF CONSCIOUSNESS 48 0.0012
882 RENAL IMPAIRMENT 101 0.0012
883 HALLUCINATION, AUDITORY 19 0.0012
884 ALOPECIA 233 0.0012
885 ANGER 40 0.0012
886 UNDERDOSE 86 0.0012
887 GENERAL PHYSICAL HEALTH DETERIORATION 136 0.0012
888 INCORRECT DOSE ADMINISTERED 268 0.0012
889 MALIGNANT NEOPLASM PROGRESSION 120 0.0012
890 DRUG EFFECT DECREASED 63 0.0012
891 STEVENS-JOHNSON SYNDROME 26 0.0012
892 DISEASE PROGRESSION 138 0.0012
893 HYPOCALCAEMIA 22 0.0012
894 OFF LABEL USE 1017 0.0012
895 INTENTIONAL DRUG MISUSE 24 0.0011
896 DRY SKIN 153 0.0011
897 LYMPHOCYTE COUNT DECREASED 20 0.0011
898 FEMUR FRACTURE 35 0.0011
899 DRUG ABUSE 94 0.0011
900 INTENTIONAL OVERDOSE 72 0.0011
901 DEATH 957 0.0011
902 INTERSTITIAL LUNG DISEASE 53 0.0011
903 METABOLIC ACIDOSIS 35 0.0011
904 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 51 0.0011
905 SHOCK 25 0.0011
906 SKIN EXFOLIATION 90 0.0011
907 TOOTH LOSS 22 0.0011
908 INJECTION SITE MASS 39 0.0011
909 ERECTILE DYSFUNCTION 27 0.0011
910 COMA 50 0.0010
911 RHEUMATOID ARTHRITIS 119 0.0010
912 CEREBRAL HAEMORRHAGE 37 0.0010
913 MENTAL IMPAIRMENT 25 0.0010
914 NEUTROPHIL COUNT DECREASED 42 0.0010
915 GLYCOSYLATED HAEMOGLOBIN INCREASED 26 0.0010
916 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 24 0.0010
917 ELECTROCARDIOGRAM QT PROLONGED 37 0.0010
918 ABDOMINAL PAIN LOWER 26 0.0010
919 DEVICE MALFUNCTION 71 0.0010
920 PSORIATIC ARTHROPATHY 41 0.0010
921 TRANSAMINASES INCREASED 22 0.0010
922 AGGRESSION 49 0.0010
923 INJECTION SITE BRUISING 78 0.0010
924 NEOPLASM MALIGNANT 65 0.0010
925 PRODUCT PRESCRIBING ISSUE 21 0.0010
926 MULTIPLE SCLEROSIS 46 0.0010
927 THERAPEUTIC PRODUCT EFFECT DECREASED 43 0.0010
928 THERAPEUTIC RESPONSE DECREASED 58 0.0010
929 DEVICE USE ERROR 33 0.0009
930 DRUG EFFECT INCOMPLETE 34 0.0009
931 SYSTEMIC LUPUS ERYTHEMATOSUS 33 0.0009
932 PSORIASIS 120 0.0009
933 DEVICE DELIVERY SYSTEM ISSUE 25 0.0009
934 INJECTION SITE PRURITUS 61 0.0009
935 VISUAL ACUITY REDUCED 30 0.0009
936 HEPATITIS 23 0.0009
937 ADVERSE EVENT 82 0.0009
938 PRODUCT SUBSTITUTION ISSUE 51 0.0009
939 MULTIPLE ORGAN DYSFUNCTION SYNDROME 25 0.0009
940 DEVICE ISSUE 79 0.0009
941 PRODUCT PREPARATION ERROR 18 0.0009
942 INJECTION SITE SWELLING 67 0.0009
943 NERVOUS SYSTEM DISORDER 27 0.0009
944 ANGIOEDEMA 38 0.0009
945 ACNE 65 0.0009
946 LIVER INJURY 21 0.0009
947 EXPOSURE DURING PREGNANCY 53 0.0009
948 MUCOSAL INFLAMMATION 22 0.0008
949 NEOPLASM PROGRESSION 29 0.0008
950 DIABETIC KETOACIDOSIS 20 0.0008
951 NEUTROPENIA 113 0.0008
952 VAGINAL HAEMORRHAGE 36 0.0008
953 PAIN OF SKIN 22 0.0008
954 ANAPHYLACTIC SHOCK 21 0.0008
955 INJECTION SITE ERYTHEMA 101 0.0008
956 PSYCHOTIC DISORDER 24 0.0008
957 SUICIDE ATTEMPT 49 0.0008
958 NEEDLE ISSUE 23 0.0008
959 TOXICITY TO VARIOUS AGENTS 133 0.0008
960 INJECTION SITE PAIN 240 0.0008
961 INJECTION SITE URTICARIA 19 0.0008
962 ECZEMA 40 0.0008
963 INJECTION SITE RASH 23 0.0007
964 CEREBRAL INFARCTION 18 0.0007
965 CARDIOVASCULAR DISORDER 18 0.0007
966 BLOOD CREATINE PHOSPHOKINASE INCREASED 20 0.0007
967 THERAPEUTIC RESPONSE SHORTENED 23 0.0007
968 COMPLETED SUICIDE 56 0.0007
969 INCORRECT ROUTE OF DRUG ADMINISTRATION 24 0.0007
970 LEUKOPENIA 33 0.0007
971 INJECTION SITE REACTION 45 0.0007
972 ABORTION SPONTANEOUS 26 0.0006
973 DEVICE LEAKAGE 28 0.0006
974 DEVICE DISLOCATION 28 0.0006
975 SKIN IRRITATION 29 0.0006
976 ACCIDENTAL EXPOSURE TO PRODUCT 62 0.0006
977 INJECTION SITE HAEMORRHAGE 48 0.0006
978 BLINDNESS 24 0.0006
979 SKIN BURNING SENSATION 41 0.0006
980 MULTIPLE SCLEROSIS RELAPSE 39 0.0006
981 DERMATITIS ATOPIC 28 0.0005
982 WITHDRAWAL SYNDROME 21 0.0005
983 DRUG WITHDRAWAL SYNDROME 43 0.0005
984 HEPATIC FUNCTION ABNORMAL 18 0.0005
985 RHABDOMYOLYSIS 20 0.0005
986 DEVICE DIFFICULT TO USE 29 0.0004
987 TREATMENT FAILURE 36 0.0004
988 DRUG DOSE OMISSION BY DEVICE 33 0.0004
989 BREAST CANCER 38 0.0004
990 PRODUCT STORAGE ERROR 35 0.0004
991 MATERNAL EXPOSURE DURING PREGNANCY 33 0.0004
992 DRUG DEPENDENCE 56 0.0003
993 PROSTATE CANCER 23 0.0003
994 FOETAL EXPOSURE DURING PREGNANCY 21 0.0003